MGMA Asks HHS to Delay Imposing MU Penalties on Physicians | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

MGMA Asks HHS to Delay Imposing MU Penalties on Physicians

August 22, 2013
by Mark Hagland
| Reprints
In an Aug. 21 letter to HHS Secretary Sebelius, the MGMA’s Susan Turney asks for leniency for MDs who have met Stage 1 MU requirements

In a letter addressed on August 21 to Kathleen Sebelius, Secretary of Health and Human Services, Susan Turney, M.D., president and CEO of the Englewood, Colo.-based Medical Group Management Association (MGMA), called on Secretary Sebelius to embrace a series of actions designed to ease the burden on physicians trying to meet the meaningful use requirements in the Health Information Technology for Economic and Clinical Health (HITECH) Act. “If the appropriate steps are not taken,” Turney wrote in the letter, “we believe physicians that have made significant investments in EHR [electronic health record] technology and successfully completed Stage 1 requirements will be unfairly subject to negative Medicare payment adjustments. Accordingly,” she wrote, “HHS should immediately institute an indefinite moratorium on penalties for physicians that successfully completed Stage 1 meaningful use requirements.”


Susan Turney, M.D.

In addition to her request for leniency on physicians who have already met the Stage 1 requirements, Turney asked Sebelius for a range of other actions, including:

> Considering the difficult circumstances of eligible professionals in small and rural clinical settings, and not requiring them to “rip and replace” existing EHRs in order to comply with the MU requirement for using certified vendor products under Stage 2.

> Extending the reporting period for Stage 2 incentives. Turney asked for a minimum of a one-year extension.

> Extending the reporting period for Stage 1 incentives, averting negative payment adjustments for physicians who have attested to Stage 1.

> Conducting a comprehensive survey of vendors, per their readiness.

> Building additional flexibility into the Stage 2 reporting requirements.

“We believe adoption of these recommendations will help ensure that the Administration’s goal of having a significant majority of our nation’s EPs adopt interoperable EHRs is kept on track and that additional fairness and flexibility is appropriately built into this important incentive program,” Turney said in her letter.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.